Clinical Trials Logo

Chronic Kidney Disease (CKD) clinical trials

View clinical trials related to Chronic Kidney Disease (CKD).

Filter by:
  • Enrolling by invitation  
  • Page 1

NCT ID: NCT06447038 Enrolling by invitation - Clinical trials for Chronic Kidney Disease (CKD)

Pilot Study for the Early Detection of Chronic Kidney Disease, Non-Dialysis Objective (NDO).

NDO
Start date: February 1, 2024
Phase:
Study type: Observational [Patient Registry]

Chronic kidney disease (CKD) is a significant public health problem worldwide, affecting more than 10% of the Spanish population. Early detection is considered a top healthcare priority to establish strategies for preventing progression to more advanced stages of the disease and its complications. Additionally, CKD is associated with high comorbidity, poor prognosis, and substantial resource consumption within the healthcare system. In this context, albuminuria may be a more sensitive marker of CKD than reduced glomerular filtration rate (GFR), and it is also considered an indicator of not only renal damage but also "systemic damage" (generalized endothelial dysfunction, arterial remodeling, and increased cardiovascular risk) beyond the kidney. Furthermore, the reduction of proteinuria/albuminuria is clearly associated with a slower progression of CKD, making its reduction a therapeutic goal as well. Given this importance, this protocol aims to determine the urine albumin/creatinine ratio in all patients over 18 years old who visit their primary care physician in the province of Burgos, Spain, and require a blood test related to their reason for consultation.

NCT ID: NCT06322641 Enrolling by invitation - Clinical trials for Chronic Kidney Disease (CKD)

A Study to Understand the Real-world Awareness and Perceptions of Systemic inFLAMmation and rolE of hsCRP as a Biomarker in Patients With AtheroSclerotic CardioVascular Disease and Chronic Kidney Disease Among Nephrologists

Start date: March 26, 2024
Phase:
Study type: Observational

The purpose of this survey is to collect information for scientific research and to better understand the role of systemic inflammation in identification, treatment and management of patients with Atherosclerotic Cardiovascular Disease (ASCVD) and Chronic Kidney Disease (CKD)